Prognostic significance of the hemoglobin–albumin–lymphocyte–platelet (HALP) score in rheumatic mitral stenosis: a long-term cohort study
Rheumatic mitral stenosis (RMS) is a chronic immune-mediated disease associated with substantial long-term morbidity and mortality. Biomarkers reflecting systemic vulnerability may complement traditional hemodynamic risk assessment. The hemoglobin–albumin–lymphocyte–platelet (HALP) score integrates inflammatory a...